|
![]() | H-05 / Protheragen (0 Trials) |
![]() | H-ferritin–nanocaged doxorubicin / Chinese Academy of Sciences, U Tokyo (0 Trials) |
![]() | H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt (11 Trials) |
![]() | H002 / Hongyun Biotech (0 Trials) |
![]() | H1299 cell lysate with iscomatrix adjuvant vaccine / National Cancer Institute (0 Trials) |
![]() | H1N1 influenza vaccine / iBio (0 Trials) |
![]() | H1N1 influenza vaccine / iBio (0 Trials) |
![]() | H2Stem / Promethera Biosciences (0 Trials) |
![]() | H3.3K27M Peptide Vaccine / University of California (0 Trials) |
![]() | H3.3K27M TCR T cell therapy / Tmunity Therap, University of California (0 Trials) |
![]() | H3B-6527 / Eisai (0 Trials) |
![]() | H3B-6545 / Eisai (3 Trials) |
![]() | H4 / Luhe Hospital, Chinese Academy of Sciences (0 Trials) |
![]() | H4 / Luhe Hospital, Chinese Academy of Sciences (0 Trials) |
![]() | H4 antagonist / Sosei (0 Trials) |
![]() | H4H1327P / Regeneron (0 Trials) |
![]() | h5A10 / Diaprost, Radiopharm Theranostics (0 Trials) |
![]() | H5N1 VLP vaccine (MT-8972) / Mitsubishi Tanabe (0 Trials) |
![]() | H5NI Influenza Vaccine / iBio (0 Trials) |
![]() | H7N9 Anhui 2013/AA ca / National Institute of Allergy and Infectious Diseases (0 Trials) |
![]() | H7N9 Anhui 2013/AA ca / National Institute of Allergy and Infectious Diseases (0 Trials) |
![]() | H7N9 vaccine (MT-7529) / Mitsubishi Tanabe (0 Trials) |
![]() | HA-1 T TCR T Cell Immunotherapy / Fred Hutchinson Cancer Research Center, ElevateBio (1 Trials) |
![]() | HA-irinotecan / ProBility Media Corp (1 Trials) |
![]() | HA121-28 / CSPC Pharma (4 Trials) |
![]() | Habeo Cell Therapy (ECCS-50) / Plus Therap (0 Trials) |
![]() | Hadlima (adalimumab biosimilar) / Organon, Merck (MSD), Biogen, Samsung, Mundipharma (3 Trials) |
![]() | Hadlima (adalimumab biosimilar) / Organon, Merck (MSD), Biogen, Samsung, Mundipharma (3 Trials) |
![]() | Haduvio (nalbuphine ER) / Trevi Therap (3 Trials) |
![]() | HAE 1 (PRO 98498) / Roche (0 Trials) |
![]() | Haegarda (C1 esterase inhibitor subcutaneous [human]) / CSL Behring (0 Trials) |
![]() | Haemate-P (human plasma derived von Willebrand factor/FVIII complex) / CSL Behring (1 Trials) |
![]() | Haemoctin (human plasma derived coagulation factor VIII) / ADMA Biologics (0 Trials) |
![]() | Haemonine (human plasma derived coagulation factor IX) / ADMA Biologics (0 Trials) |
![]() | Haemonine (human plasma derived coagulation factor IX) / ADMA Biologics (0 Trials) |
![]() | Hakin-1 / Angélica Figueroa of University of A Coruña (0 Trials) |
![]() | HAL-MPE1 / HAL Allergy (0 Trials) |
![]() | Halaven (eribulin mesylate) / Eisai (68 Trials) |
![]() | halcinonide / Generic mfg. (0 Trials) |
![]() | Halfan (halofantrine) / GSK (0 Trials) |
![]() | Haloart (halopredone) / LTT Bio-Pharma (0 Trials) |
![]() | Haloart (halopredone) / LTT Bio-Pharma (0 Trials) |
![]() | haloperidol / Generic mfg. (28 Trials) |
![]() | haloperidol (CLR3001) / Clera (0 Trials) |
![]() | haloperidol/trihexyphenidyl / Generic mfg. (0 Trials) |
![]() | Halovirin nCov / Halo-Bio (0 Trials) |
![]() | Halpryza (rituximab biosimilar) / Innovent Biologics, Eli Lilly (0 Trials) |
![]() | Hamsa 1 (TL 118) / Tiltan Pharma (0 Trials) |
![]() | Hamsa 1 (TL 118) / Tiltan Pharma (0 Trials) |
![]() | Hamsa-1 (TL-118) / Tiltan Pharma (0 Trials) |
![]() | Hamsyl (peg-aspargase biosimilar) / Emcure (0 Trials) |
![]() | Hanbeitai (bevacizumab biosimilar) / Fosun Pharma (6 Trials) |
![]() | Handayuan (adalimumab biosimilar) / Fosun Pharma (0 Trials) |
![]() | Hanferon Oral (interferon alpha-2b oral) / Daewoong Pharma (0 Trials) |
![]() | Hanferon SC (interferon alpha-2b) / Daewoong Pharma (0 Trials) |
![]() | Hanferon SC (interferon alpha-2b) / Daewoong Pharma (0 Trials) |
![]() | Hanlikang (rituximab biosimilar) / Fosun Pharma, Eurofarma, AbbVie, Farma de Colombia (2 Trials) |
![]() | HANP (carperitide) / Zeria Pharma, Daiichi Sankyo (0 Trials) |
![]() | Hansizhuang (serplulimab) / Fosun Pharma (27 Trials) |
![]() | Hansoh Xinfu (flumatinib) / Jiangsu Hengrui Medicine, Jiangsu Hansoh Pharma (10 Trials) |
![]() | HAPC1573 / Bayer, Shanghai RAAS (0 Trials) |
![]() | haploid allogeneic NK cell therapy / iCELL Biotechnology (1 Trials) |
![]() | haploid allogeneic NK cell therapy / iCELL Biotechnology (1 Trials) |
![]() | Haruropi tape (ropinirole transdermal) / Hisamitsu, Kyowa Kirin (0 Trials) |
![]() | HB-001 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB-002 / Zhejiang Huahai Pharma (1 Trials) |
![]() | HB-1 / Honeybrains Biotech (1 Trials) |
![]() | HB-101 / Hookipa Pharma (0 Trials) |
![]() | HB-110E / Genexine (0 Trials) |
![]() | HB-110E / Genexine (0 Trials) |
![]() | HB-121 / Healion Bio (0 Trials) |
![]() | HB-201 / Hookipa Pharma (2 Trials) |
![]() | HB-202 / Hookipa Pharma (2 Trials) |
![]() | HB-300 / Hookipa Pharma (0 Trials) |
![]() | HB-700 / Hookipa Pharma (0 Trials) |
![]() | HB-adMSC / Hope Biosciences (8 Trials) |
![]() | HB-adMSC / Hope Biosciences (8 Trials) |
![]() | HB-AS 02 / GSK (1 Trials) |
![]() | HB0017 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB002.1M / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0025 / Zhejiang Huahai Pharma (1 Trials) |
![]() | HB0028 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0030 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0030 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0034 / Zhejiang Huahai Pharma (2 Trials) |
![]() | HB0036 / Zhejiang Huahai Pharma (1 Trials) |
![]() | HB0039 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0043 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB0052 / Zhejiang Huahai Pharma (0 Trials) |
![]() | HB007 / HB Therap (0 Trials) |
![]() | HB007 / HB Therap (0 Trials) |
![]() | HBI 0201-ESO TCRT / Hadassah Medical Organization (1 Trials) |
![]() | HBI-2376 / HUYA Bioscience (2 Trials) |
![]() | HBI-2438 / HUYA Bioscience (1 Trials) |
![]() | hBM-MSC / Translational Research Center for Medical Innovation (0 Trials) |
![]() | HBM1007 / Harbour BioMed (0 Trials) |
![]() | HBM1020 / Harbour BioMed (0 Trials) |
![]() | HBM1020 / Harbour BioMed (0 Trials) |
![]() | HBM1022 / Harbour BioMed (0 Trials) |
![]() | HBM1029 / Harbour BioMed (0 Trials) |
![]() | HBM4003 / Harbour BioMed (5 Trials) |
![]() | HBM7008 / Harbour BioMed (1 Trials) |
![]() | HBM7015 / Harbour BioMed (0 Trials) |
![]() | HBM7020 / Harbour BioMed, Hualan Biological Engineering (0 Trials) |
![]() | HBM7020 / Harbour BioMed, Hualan Biological Engineering (0 Trials) |
![]() | HBM7022 / AstraZeneca (0 Trials) |
![]() | HBM9001 / Sichuan Kelun Pharma, Harbour BioMed (0 Trials) |
![]() | HBM9022 / Utrecht University, Erasmus MC, Harbour BioMed, AbbVie (0 Trials) |
![]() | HBM9027 / Harbour BioMed (0 Trials) |
![]() | HBP-bound-doxorubicin (12B80) / Atlanthera (0 Trials) |
![]() | HBS-102 / Paragon Biosci (0 Trials) |
![]() | HBS-102 / Paragon Biosci (0 Trials) |
![]() | HBV surface antigen secretion inhibitors / Arbutus (0 Trials) |
![]() | HBV therapeutic vaccine / IMV Inc (0 Trials) |
![]() | HBV vaccine / ProMed BioSci (0 Trials) |
![]() | HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) / GSK (2 Trials) |
![]() | HBVaxPro (hepatitis-B vaccine (rDNA)) / Merck (MSD), Sanofi (5 Trials) |
![]() | HBW-3-10 / Hyperway Pharma (0 Trials) |
![]() | HBW-3-10 / Hyperway Pharma (0 Trials) |
![]() | HBW-3-20 / Hyperway Pharma (0 Trials) |
![]() | HBW-3090 / Hyperway Pharma (0 Trials) |
![]() | HC-5404-FU / HiberCell (1 Trials) |
![]() | HC-7366 / HiberCell (1 Trials) |
![]() | HC-X014 / Hinova Pharma (0 Trials) |
![]() | HC-X027 / Hinova Pharma (0 Trials) |
![]() | HC-X027 / Hinova Pharma (0 Trials) |
![]() | HC-X029 / Hinova Pharma (0 Trials) |
![]() | HCB1019 / OcuNexus (0 Trials) |
![]() | hCD19 CAR-T cells / Affiliated Hospital of Xuzhou Medical University (0 Trials) |
![]() | HCI-1401 / HLB Bio Group (0 Trials) |
![]() | HCP1803 / Hanmi (1 Trials) |
![]() | HCP1904 / Hanmi (4 Trials) |
![]() | HCP1904 / Hanmi (4 Trials) |
![]() | HCP2102 / Hanmi (1 Trials) |
![]() | HCR040 / Noray (2 Trials) |
![]() | hCT-MSC / Duke University (1 Trials) |
![]() | HCV E1E2/MF59C / Novartis (0 Trials) |
![]() | HCV vaccine / VBI Vaccines (0 Trials) |
![]() | HCVax (lentiviral based HCV immunotherapy) / GeneCure Biotechnologies (1 Trials) |
![]() | HCVax (lentiviral based HCV immunotherapy) / GeneCure Biotechnologies (1 Trials) |
![]() | HCW9207 / HCW Biologics (0 Trials) |
![]() | HCW9218 / HCW Biologics (2 Trials) |
![]() | HCW9302 / HCW Biologics (0 Trials) |
![]() | HD-003 / Hyundai Pharm (0 Trials) |
![]() | HD-6277 / Hyundai Pharm (0 Trials) |
![]() | HD-7671 / Hyundai Pharm (0 Trials) |
![]() | HD-7671 / Hyundai Pharm (0 Trials) |
![]() | HD-CAR-1 / Heidelberg University Hospital (1 Trials) |
![]() | HD205 / Hanwha Chem (0 Trials) |
![]() | HDAC inhibitor / Alkermes (0 Trials) |
![]() | HDDO-1756 / Hyundai Pharm (0 Trials) |
![]() | HDIT101 / Heidelberg ImmunoTherap (1 Trials) |
![]() | HDL receptor enhancer / Abionyx Pharma (0 Trials) |
![]() | HDL receptor enhancer / Abionyx Pharma (0 Trials) |
![]() | HDM-SPIRE / Circassia (0 Trials) |
![]() | HDP-101 / Heidelberg Pharma (1 Trials) |
![]() | HDP-102 / Heidelberg Pharma (0 Trials) |
![]() | HDP-103 / Heidelberg Pharma (0 Trials) |
![]() | HDP-104 / Heidelberg Pharma (0 Trials) |
![]() | HDV insulin lispro (HDV-L) / Diasome (0 Trials) |
![]() | HDV insulin lispro (HDV-L) / Diasome (0 Trials) |
![]() | HDV-interferon (interferon alpha controlled-release) / Hepasome Pharma (0 Trials) |
![]() | HE-33 / Immune Modulation (0 Trials) |
![]() | HE3177 / Harbor Biosci (0 Trials) |
![]() | HE3413 / Harbor Biosciences (0 Trials) |
![]() | head and neck cancer vaccine / Vyriad (0 Trials) |
![]() | Healive (Hepatitis A vaccine inactivated) / Sinovac (0 Trials) |
![]() | Healive (Hepatitis A vaccine inactivated) / Sinovac (0 Trials) |
![]() | Heartcel (iMP cell therapy) / Celixir (0 Trials) |
![]() | Hearticellgram-AMI (Autologous bone marrow derived mesenchymal stem cells) / Pharmicell (1 Trials) |
![]() | Heberitro (epoetin alfa biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
![]() | HeberNasvac (ABX203) / Center for Genetic Engineering and Biotechnology, Abivax (0 Trials) |
![]() | HEBERSaVax (CIGB-247) / Center for Genetic Engineering and Biotechnology, Heber Biotec (0 Trials) |
![]() | Hebervital (filgrastim biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
![]() | Hebervital (filgrastim biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
![]() | HEC-016 / Shenzhen Fifth People's Hospital (1 Trials) |
![]() | HEC116094 / HEC Pharm (1 Trials) |
![]() | HEC121120 / HEC Pharm (1 Trials) |
![]() | HEC122505MsOH / HEC Pharm (1 Trials) |
![]() | HEC169096 / HEC Pharm (1 Trials) |
![]() | HEC53856 / HEC Pharm (2 Trials) |
![]() | HEC53856 / HEC Pharm (2 Trials) |
![]() | HEC68498 / HEC Pharm (0 Trials) |
![]() | HEC73077 / HEC Pharm (1 Trials) |
![]() | HEC80797 / HEC Pharm (0 Trials) |
![]() | HEC83518 / HEC Pharm (2 Trials) |
![]() | HEC89736 / HEC Pharm (1 Trials) |
![]() | HEC96719 / HEC Pharm (1 Trials) |
![]() | HEC96719 / HEC Pharm (1 Trials) |
![]() | Hecolin (recombinant hepatitis E vaccine) / Wantai BioPharm (2 Trials) |
![]() | Heliocare (polypodium leucotomos extract) / Ferndale (0 Trials) |
![]() | Helios ocular insert (bimatoprost sustained release insert) / AbbVie (0 Trials) |
![]() | Helix Partner-02 / BioCardia (0 Trials) |
![]() | Hemady (dexamethasone tablets) / Dexcel Pharma (35 Trials) |
![]() | HemaMax (rHuIL-12) / Neumedicines (0 Trials) |
![]() | HemaMax (rHuIL-12) / Neumedicines (0 Trials) |
![]() | Hemapo (epoetin alfa biosimilar) / PT Kalbe Farma, Alliance, CIMAB (0 Trials) |
![]() | Hemaseel HMN (fibrin sealant) / Haemacure (0 Trials) |
![]() | hematologic Tumor Accurin / Pfizer (0 Trials) |
![]() | Hemay005 / Tianjin Hemay Pharma (5 Trials) |
![]() | Hemay007 / Tianjin Hemay Pharma (2 Trials) |
![]() | Hemay022 / Tianjin Hemay Pharma (3 Trials) |
![]() | Hemay022 / Tianjin Hemay Pharma (3 Trials) |
![]() | Hemay808 / Tianjin Hemay Pharma (0 Trials) |
![]() | Hemlibra (emicizumab-kxwh) / Roche (25 Trials) |
![]() | Hemo-8r (recombinant coagulation factor VIII) / Hemobras (0 Trials) |
![]() | HEMO-CAR-T / Hemogenyx, University of Pennsylvania (0 Trials) |
![]() | Hemodynamic modulator / Boehringer Ingelheim (0 Trials) |
![]() | Hemofil-M (human plasma derived coagulation factor VIII) / Takeda (0 Trials) |
![]() | Hemofil-M (human plasma derived coagulation factor VIII) / Takeda (0 Trials) |
![]() | hemophilia A cell therapy / Sernova (0 Trials) |
![]() | hemophilia A lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
![]() | hemophilia A therapeutic / Recursion Pharma (0 Trials) |
![]() | hemophilia A therapeutic / Lambdagen Therap (0 Trials) |
![]() | hemophilia A therapeutic / Generation Bio (0 Trials) |
![]() | hemophilia A therapeutic / Precision BioSci (0 Trials) |
![]() | hemophilia A therapeutic / Precision BioSci (0 Trials) |
![]() | hemophilia A therapy / Immusoft (0 Trials) |
![]() | hemophilia B lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
![]() | Hemophilia specific therapeutic antibody / Initium Therap (0 Trials) |
![]() | hemophilia therapy / 3B Pharma, Takeda (0 Trials) |
![]() | Hemoraas (plasma-derived human coagulation factor VIII) / Tonrol Biopharm (0 Trials) |
![]() | HemoRel A (anti - hemophilic factor) / Reliance Life Sci (0 Trials) |
![]() | HemoRel A (anti - hemophilic factor) / Reliance Life Sci (0 Trials) |
![]() | hemp extract (CDE-001) / Emerald Health Research (0 Trials) |
![]() | henagliflozin (SHR3824) / Jiangsu Hengrui Medicine (2 Trials) |
![]() | henagliflozin/metformin (HR20033) / Jiangsu Hengrui Medicine (2 Trials) |
![]() | henatinib / Shanghai Inst. of Materia Medica, Jiangsu Hengrui Medicine (0 Trials) |
![]() | Hengmu (tenofovir amibufenamide) / Jiangsu Hansoh Pharma (3 Trials) |
![]() | Hengqu (hetrombopag) / Jiangsu Hengrui Pharma (19 Trials) |
![]() | Hengqu (hetrombopag) / Jiangsu Hengrui Pharma (19 Trials) |
![]() | Henletor (torsemide) / Orchid (5 Trials) |
![]() | Hensify (crystalline hafnium oxide) / Nanobiotix (9 Trials) |
|